Proqr Therapeutics Bv Stock Alpha and Beta Analysis
| PRQR Stock | USD 3.84 0.17 4.63% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ProQR Therapeutics BV. It also helps investors analyze the systematic and unsystematic risks associated with investing in ProQR Therapeutics over a specified time horizon. Remember, high ProQR Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ProQR Therapeutics' market risk premium analysis include:
Beta 3.16 | Alpha 1.25 | Risk 15.71 | Sharpe Ratio 0.12 | Expected Return 1.81 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ProQR |
ProQR Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ProQR Therapeutics market risk premium is the additional return an investor will receive from holding ProQR Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ProQR Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ProQR Therapeutics' performance over market.| α | 1.25 | β | 3.16 |
ProQR Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ProQR Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how ProQR Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ProQR Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how ProQR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProQR Therapeutics shares will generate the highest return on investment. By understating and applying ProQR Therapeutics stock market price indicators, traders can identify ProQR Therapeutics position entry and exit signals to maximize returns.
ProQR Therapeutics Return and Market Media
The median price of ProQR Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.0 with a coefficient of variation of 35.15. The daily time series for the period is distributed with a sample standard deviation of 0.96, arithmetic mean of 2.73, and mean deviation of 0.93. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ProQR Therapeutics Stock Price Passes Below 200 Day Moving Average of 1.95 - MarketBeat | 09/27/2024 |
2 | ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society | 10/07/2024 |
3 | Gevo And 2 Other US Penny Stocks To Watch Closely | 10/21/2024 |
4 | ProQR Prices 75 Million Underwritten Public Offering and Concurrent Private Placement | 10/23/2024 |
5 | ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement | 10/25/2024 |
6 | ProQR Announces Third Quarter 2024 Operating and Financial Results | 11/07/2024 |
7 | ProQR Therapeutics Shares Cross Above 50 Day Moving Average - Time to Sell - MarketBeat | 11/21/2024 |
About ProQR Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ProQR or other stocks. Alpha measures the amount that position in ProQR Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2020 | 2021 | 2023 | 2024 (projected) | Payables Turnover | 9.93 | 6.32 | 0.0866 | 0.0823 | Days Of Inventory On Hand | 63.05 | 1.01 | 1.16 | 1.11 |
ProQR Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of ProQR Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ProQR Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ProQR Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ProQR Therapeutics. Please utilize our Beneish M Score to check the likelihood of ProQR Therapeutics' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with ProQR Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.